Evolus EOLS 深 滬
已收盤 08-08 16:00:00 美东时间
5.90
-0.170
-2.80%
華盛通- 最 高6.0796
- 今 開6.07
- 成交量 272.31万股
- 最 低 5.86
- 昨 收 6.07
- 總市值 3.80亿
- 52周最高 17.82
- 市盈率 靜 --
- 換手率 4.22%
- 52周最低 5.85
- 委 比 -62.40%
- 總股本 6447.56万
- 歷史最高 39.50
- 量 比 0.55
- 振 幅 3.62%
- 歷史最低 2.85
- 每 手 1
- 風險率 2.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Needham Downgrades Evolus to Hold, Maintains Price Target to $22
Needham analyst Serge Belanger downgrades Evolus (NASDAQ:EOLS) from Buy to Hold and maintains the price target from $22 to $22.
08-06 20:34
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Shares of Astera Labs, Inc. (NASDAQ:ALAB) rose sharply in pre-market trading af...
08-06 17:35
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BiomX (AMEX:PHGE) shares moved upwards by 40.1% to $0.61 during Tuesda...
08-06 05:07
Evolus Appoints New Principal Financial Officer
The latest update is out from Evolus ( ($EOLS) ). On August 1, 2025, Evolus app...
08-06 04:47
Evolus Lowers FY2025 Sales Guidance from $345.000M-$355.000M to $295.000M-$305.000M vs $348.308M Est
Evolus (NASDAQ:EOLS) lowers FY2025 sales outlook from $345.000 million-$355.000 million to $295.000 million-$305.000 million vs $348.308 million estimate.
08-06 04:19
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
A Look Ahead: Evolus's Earnings Forecast
Evolus (NASDAQ:EOLS) will release its quarterly earnings report on Tuesday, 202...
08-05 03:04
Evolus Announces Study In "JAMA Dermatology", Finds Jeuveau Outperforms Botox, Dysport, and Xeomin In Onset, Peak Effect, And Duration
First head-to-head study of four United States (U.S.) Food & Drug Administration (FDA) approved neurotoxins: Jeuveau®, Botox®, Dysport®, and Xeomin®The study published in JAMA Dermatology supports
07-31 20:10
Evolus Partners With Symatese To Commence Distribution Of Nuceiva In France
Launching into this key growth market as part of the company's geographic expansion strategyEvolus to provide Nuceiva® to French medical aesthetics healthcare professionals through its partnership with Symatese
07-09 20:04
Evolus CFO Sandra Beaver Announces Resignation
Evolus ( ($EOLS) ) has issued an update. On May 27, 2025, Evolus, Inc. announce...
05-28 04:52
